Biospecifics Technologies Corp (NASDAQ:BSTC)

37.95
Delayed Data
As of Mar 27
 +0.44 / +1.17%
Today’s Change
22.23
Today|||52-Week Range
42.00
-1.73%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$255.9M

Company Description

BioSpecifics Technologies Corp. is a biopharmaceutical company, which engages in development of an injectable collagenase for multiple indications. Its product XIAFLEX is an injectable collagenase enzyme, which is used for the treatment of Dupuytren's contracture in adults with a palpable cord in the palm. The company was founded in 1990 and is headquartered in Lynbrook, NY.

Contact Information

Biospecifics Technologies Corp.
35 Wilbur Street
Lynbrook New York 11563
P:(516) 593-7000
Investor Relations:

Employees

Shareholders

Individual stakeholders40.36%
Other institutional37.42%
Mutual fund holders17.27%

Top Executives

Thomas L. WegmanPresident, CEO, CFO, Director & CAO
Patrick CaldwellExecutive
James GorisController

To view my watchlist

Not a member yet?

Sign up now for a free account